Safety and clinical activity results from a phase Ib study of alectinib plus atezolizumab in ALK+ advanced NSCLC (aNSCLC) Meeting Abstract
| Authors: | Kim, D. W.; Gadgeel, S. M.; Gettinger, S. N.; Riely, G. J.; Oxnard, G. R.; Mekhail, T.; Schmid, P.; Dowlati, A.; Heist, R. S.; Wozniak, A. J.; Hernandez, G.; Sarkar, I.; Mitry, E.; Foster, P.; O'Hear, C.; Spahn, J.; Ou, S. H. I. |
| Abstract Title: | Safety and clinical activity results from a phase Ib study of alectinib plus atezolizumab in ALK+ advanced NSCLC (aNSCLC) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 462s |
| Language: | English |
| ACCESSION: | WOS:000442916003183 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.9009 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9009 -- Source: Wos |
